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Abstract
Background: The purpose of this study was to compare dose distributions from three different algorithms with
the x-ray Voxel Monte Carlo (XVMC) calculations, in actual computed tomography (CT) scans for use in stereotactic
radiotherapy (SRT) of small lung cancers.
Methods: Slow CT scan of 20 patients was performed and the internal target volume (ITV) was delineated on
Pinnacle
3. All plans were first calculated with a scatter homogeneous mode (SHM) which is compatible with Clarkson
algorithm using Pinnacle
3 treatment planning system (TPS). The planned dose was 48 Gy in 4 fractions. In a second
step, the CT images, structures and beam data were exported to other treatment planning systems (TPSs). Collapsed
cone convolution (CCC) from Pinnacle
3, superposition (SP) from XiO, and XVMC from Monaco were used for
recalculating. The dose distributions and the Dose Volume Histograms (DVHs) were compared with each other.
Results: The phantom test revealed that all algorithms could reproduce the measured data within 1% except for
the SHM with inhomogeneous phantom. For the patient study, the SHM greatly overestimated the isocenter (IC)
doses and the minimal dose received by 95% of the PTV (PTV95) compared to XVMC. The differences in mean
doses were 2.96 Gy (6.17%) for IC and 5.02 Gy (11.18%) for PTV95. The DVH’s and dose distributions with CCC and
SP were in agreement with those obtained by XVMC. The average differences in IC doses between CCC and XVMC,
and SP and XVMC were -1.14% (p = 0.17), and -2.67% (p = 0.0036), respectively.
Conclusions: Our work clearly confirms that the actual practice of relying solely on a Clarkson algorithm may be
inappropriate for SRT planning. Meanwhile, CCC and SP were close to XVMC simulations and actual dose
distributions obtained in lung SRT.
Keywords: Monte Carlo, Calculation algorithm, Stereotactic body radiotherapy (SBRT), Lung cancer, Tissue
inhomogeneities
Background
Lung cancer is the leading cause of cancer-related death
for men in the world [1], and there are no indications of
a decrease in the number of these mortalities. Recently,
because of the application of computed tomography
(CT) for lung cancer screening, the number of patients
diagnosed with early-stage non-small cell lung cancer
(NSCLC) has increased. At present, stereotactic radia-
tion therapy (SRT) is considered as a therapeutic option
in early stage lung cancer for inoperable patients or for
patients refusing surgery. SRT has the advantage of
being a minimally-invasive procedure, as well as having
a relatively short duration of the course of treatment. In
addition, SRT continues to show much better outcomes
than those of conventional radiotherapy [2,3].
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human body, it is very important for SRT planning to
take into account differences in tissue density in the
dose computation and to consider the secondary elec-
tron transport accurately. Therefore, the use of hetero-
geneity correction and different types of algorithms have
been reported to significantly influence the accuracy of
the absolute dose [4,5].
To confirm safety and efficacy, SRT for lung cancer is
still under evaluation in multi-institutional clinical trials.
For example, the Japan Clinical Oncology Group
(JCOG) conducted a phase II study 0403 of SRT in
operable and medically inoperable patients with patholo-
gically proven T1N0M0 non-small cell lung cancer
(NSCLC) to evaluate efficacy and safety. Patient accrual
for operable cases and their 3-year follow up was com-
pleted in February 2010 [6]. Moreover, JCOG 0702, a
phase I dose escalation study of SRT in patients medi-
c a l l yi n o p e r a b l eo ru n f i tf o rs urgery with pathologically
proven T2N0M0 NSCLC, was started to determine the
recommended dose. In this context, in JCOG 0403, the
prescribed dose was 48 Gy at the isocenter in 4 fractions
and heterogeneity corrected doses by pencil beam con-
volution (PBC) algorithms were used since PBC could
commonly be used in almost all clinical practices at that
time. However, at the present time it is well known that
PBC has shortcomings when it comes to severe inhomo-
geneities [7,8]. As for lung cancer treatments, the actual
dose is to be lower than expected. In JCOG 0702, there-
fore, the prescription was changed and the planning
objective was for 95% of the PTV to be covered by the
some isodose (i.e., 50 Gy) with superposition (SP) or
other newer algorithm than Clarkson.
Several studies have been conducted on the accuracy
of inhomogeneity corrections employing various algo-
rithms. Most of these studies, however, focus on evalu-
ating the dose to the phantom [9,10]. Koelbel et al. [11]
found that the Pencil Beam (PB) algorithm overesti-
mates the dose to targets in the lung as compared to
CCC. These reports were not examined in any real
patient. Fragoso et al. [12] reported that XVMC is more
accurate than PB in SRT. This report, however, com-
pared only two algorithms and was limited for only
three patients.
In contrast, the present work summarized four differ-
ent dose calculations of actual SRT cases with 20 lung
cancer patients after dosimetry measurements on an
inhomogeneous phantom. The following four dose-cal-
culation algorithms were compared: scatter homoge-
neous mode (SHM) and CCC available in Pinnacle
3
(Philips
©), SP implemented in XiO (ELEKTA
©), and
XVMC implemented in Monaco (ELEKTA
©). This study
did not include both PB and Clarkson algorithms.
Instead, the SHM calculation corresponding Clarkson
calculation was employed. Sharing a common plan, dose
volume histograms (DVHs) calculated by these algo-
rithms were analyzed to quantify the dose to the targets
and lung as an organ at risk (OAR). Furthermore, mean
dose, and mean relative difference were employed to
assess the algorithms.
Methods
Subjects
A retrospective study was conducted on 20 consecutive
patients with lung cancer who underwent SRT at the
University of Tokyo Hospital from October 2009 to
August 2010. The internal target volume (ITV) ranged
from 2.3 to 42.2 cc (median, 8.7 cc). Patient characteris-
tics are summarized in Table 1.
Treatment planning
CT images for treatment planning were acquired using
Aquillion™LB (TOSHIBA
©) after patients were posi-
tioned in a stereotactic body frame (SBF; ELEKTA
©)i n
the supine position. An SBF-attached template on the
patient’s abdomen reduced the mobility of the target
[13]. The CT images were acquired with one mm thick
slices around the tumor and five-mm-slices elsewhere
using the “long-scan-time” technique, which visualized a
major part of the trajectory of tumor movement by
scanning each slice for a long time [14]. Slow CT scan
was performed during four seconds with abdominal
compression.
Table 1 Characteristics of 20 patients
Case No. ITV (cc) PTV (cc) Location
1 9.4 31.4 Rt S1
2 5.1 22.2 Rt S6
3 29.8 74.6 Rt S10
4 8.4 30.3 Rt S3
5 4.0 17.4 Lt S1+2
6 9.6 33.0 Rt hilum
7 16.9 48.5 Lt S1+2
8 15.6 45.7 Lt S10
9 8.7 33.6 Rt S8
10 7.6 29.1 Rt S8
11 7.5 26.7 Rt S8
12 41.1 98.3 Rt hilum
13 9.7 33.3 Rt S3
14 8.8 30.7 Rt S8
15 42.2 98.8 Lt S1+2
16 3.8 16.2 Lt S1+2
17 2.3 12.2 Lt S8
18 38.9 85.4 Rt S10
19 2.3 12.1 Rt S5
20 6.6 23.0 Rt S3
Abbreviation; ITV, internal target volume. PTV, planning target volume.
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tion treatment planning system (3D RTPS) (Pinnacle
3
Version 7.4i, Philips
©) using the lung window of the CT
scan for treatment planning. For each case, ITVs and
OARs were defined manually slice by slice by the same
radiation oncologist. In all cases, planning target
volumes (PTVs) were created by adding five mm mar-
gins to the ITVs in all directions, and generated using
the automatic three-dimensional (3D) contour genera-
tion tool of Pinnacle
3. All calculations were performed
with a grid size of 2.0 mm.
Since the JCOG 0403 protocol has involved the older
algorithms, such as the PB and Clarkson algorithm, all
plans were first calculated with a SHM calculation ignor-
ing a heterogeneous scatter in Pinnacle
3. The planned
dose was 48 Gy in four fractions, using static beams
(eight ports); the gantry and couch angles were 180° + 0°,
260° + 0°, 340° + 0°, 30° + 40°, 35° + 320°, 320° + 320°, 30°
+ 90°, 330° + 90°, respectively. All plans had 6 MV non-
coplanar and non-opposing rectangular beams.
In the second step, the CT images and structures,
such as PTV and organs at risk (OAR), and beam data
were exported to the Xio TPS and the Monaco TPS.
Special care was taken to preserve the same exact plan
(keeping the monitor units (MUs), beam weights and
fixed angles) in all algorithms. Then, three other dose
algorithms were used for recalculating: collapsed cone
convolution (CCC) from Pinnacle
3 ver.7.4i, and superpo-
sition from XiO ver.4.4 (ELEKTA
©), and XVMC from
Monaco ver.2.03.01 (ELEKTA
©).
In Pinnacle CCC dose calculation, to account for
inhomogeneity, the kernels are density-scaled during
superposition that is performed by using “collapsed
cones”, which refer to the modeling of a cone in space
using a single ray corresponding to the central axis of
the cone. The polyenergetic kernels were constructed
with Monte Carlo-generated energy deposition cones
[15,16]. In the Xio superposition dose calculation
method, a fanned grid is created and dose is computed
by convolving the total energy released with Monte
Carlo-generated energy deposition kernels which are
represented in spherical coordinates [17]. For more
accurate calculation in inhomogeneous tissues the ker-
nels are allowed to change with the local electron den-
sity variations and to reduce calculation time by using
the multi-grid superposition method [18]. The XVMC
dose engine implemented in Monaco (ELEKTA
©)w a s
applied in this study. Kawrakow et al. [19] developed
VMC as a fast calculation engine for electron beams,
and VMC was later extended to photon beams as
XVMC [20]. The dose calculation cube voxel size and
the statistical uncertainty of the XVMC dose calculation
in this study were 2 × 2 × 2 mm
3 and 1%, respectively.
All of the TPS’s were installed in the Department of
Radiology, University of Tokyo hospital, and were com-
missioned for a 6 MV photon beam provided by an
Synergy linear accelerator (ELEKTA
©).
Phantom testing
To validate the reliability of the comparison among var-
ious algorithms, it is required to verify the accuracy of
beam modeling in each TPS. After a commissioning
recommended by vendors, therefore, the verification of
each TPS for a small field size was performed on a
water phantom (RT-3000-New-Water, R-tech, Japan)
and an inhomogeneous phantom with a spherical insert
of 3 cm diameter (RT-3000-New-Water with cork, R-
tech, Japan), which was placed on the middle of the
cork. The isocenter was located on the middle of these
phantoms. All calculations were performed with volume
f o rag r i ds i z e2×2×2m m
3 by using the actual CT
images with a CT-to-density table of Aquillion™LB.
The comparison was made with a 3 × 3 cm
2 single
beam in the water phantom and the same eight non-
coplanar beams of 4 × 4 cm
2 as shown in previous sub-
section in the inhomogeneous phantom. These results
were compared with the measurement at isocenter
using a pinpoint ion chamber (PTW, Germany).
Treatment plan evaluation
The dose distributions were compared with each other.
This study also evaluated the shape differences of the dose
volume histograms (DVHs) for the different calculations
using the same plan. For each treatment plan, the mini-
mal, maximal, and median relative doses in the ITV and
PTV were compared and the differences calculated. The
paired t-test was used to examine the differences in dose
volume indices between different algorithms. A probability
value of less than 0.05 was considered to be significant.
Results
Phantom testing
The result of dose calculation using phantoms is summar-
ized in Table 2. The dose difference from the measure-
ment was less than 1% in all algorithms with a 3 × 3 cm
2
field size in the water phantom. The calculation results
with non-coplanar eight beams showed that the algo-
rithms except for SHM can reproduce the measurement
data very well even though the inhomogeneous phantom
was employed. As expected, the SHM algorithm had a
large error in the inhomogeneous phantom, where the
scattered photons contributed to the dose significantly.
The phantom test also revealed no large differences
among XVMC, CCC and SP algorithms in the IC dose.
Evaluation of dose distributions in 20 patients
Figure 1 shows the dose distributions obtained with
SHM, CCC, SP and XVMC at the isocenter plane, with
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Page 3 of 8the ITV (green line) and PTV (blue line) in axial view of
case 11. Figure 2 also shows the dose distributions in
case 13. Although small differences between these algo-
rithms can be seen in these figures, CCC and SP agreed
reasonably well in this clinical case (within +/- 2.5% of
Dmax) with the XVMC simulations (Table 3). On the
other hand, SHM gave overestimated doses in IC and
PTV95. This was also observed in the dose volume his-
tograms in case 13 (Figure 3).
In order to see the difference among algorithm more
clearly, the dose profiles in the longitudinal direction are
depicted in Figures 4(a) and 4(b), for case 11 and case
13, respectively. These figures show that all algorithms
except SHM estimate the dose to the target in a rela-
tively accurate way, while the SHM gives less good
agreement than all other algorithms within ITV. The
large discrepancy between SHM and others is mainly
caused by the build up and the scatter around the lung/
Table 2 Comparison of IC doses in four algorithms with the measeured doses
Pinpoint chamber SHM error CCC error SP error MC error
[cGy] [cGy] [%] [cGy] [%] [cGy] [%] [cGy] [%]
Single Beam (3 × 3 cm
2) in Water Phantom
a) 124.6 124.0 0.48 124.4 0.16 125.5 -0.72 123.9 0.56
Eight Beams (4 × 4 cm
2) in inhomogeneous Phantom
b) 200.9 209.6 -4.33 199.9 0.50 200.6 0.15 201.7 -0.40
Abbreviations: SHM, scatter homogeneous mode, CCC, C.C.Convolution, SP, Superposition, MC, Monte Carlo.
a) Single delivery of 200MU from gantry angle of 0 degree.
b) Static 8 beams; the gantry, couch angles and MU were 180° + 0° 33.5MU, 260° + 0° 44.3MU, 340° + 0° 33.6MU, 30° + 40° 34.1MU, 35° + 320° 35.3MU, 320° +
320° 36.1MU, 30° + 90° 34.4MU, 330° + 90° 34.5MU, respectively. The MU employed here has equal weights in IC dose of CCC in inhomogeneous phantom.
Figure 1 IC Dose (case 11: Right S8 NSCLC). Isodose lines at the isocenter plane calculated with SHM (upper left), CCC (lower left), SP (upper
right) and XVMC (lower right) for lung case 11. The ITV (green line) and the PTV (blue line) are shown in the left figure.
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credible. On the other hand, the fact that the dose pro-
files of MC and SP are similar each other indicates that
the SP algorithm can also reproduce the dose of the
lung/ITV interface well.
Comparison of dose-volume histograms of SHM, CCC, SP
and XVMC
The dose distributions for the ITV, PTV, and OAR
structures show differences between the four algorithms,
and this can be appreciated in the DVH in case 13. Fig-
ure 3 shows the DVH comparison of calculations with
SHM, CCC, SP and XVMC. The blue lines are for lung
dose (Lung-PTV), the black lines for ITV, and the red
lines for PTV.
As can be seen in Figure 3, SHM had a tendency to
produce higher dose distributions in ITV and PTV than
the other algorithms. On the other hand, lung doses
(bilateral lung volume minus ITV) were almost the
same among all four algorithms. While SHM showed
Figure 2 IC Dose (case13: Left S3 NSCLC). Isodose lines at the isocenter plane calculated with SHM (upper left), CCC (lower left), SP (upper
right) and XVMC (lower right) for lung case 13. The ITV (green line) and the PTV (blue line) are shown in the left figure.
Table 3 Characteristics and dose-volume parameters of the different dose calculations
Structure Parameter SHM CCC SP MC CCC vs. SP CCC vs. MC SP vs. MC
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean [%] p-Value Mean [%] p-Value Mean [%] p-Value
IC dose(Gy) 48.00 (0.0) 45.35 (1.3) 46.04 (1.4) 44.84 (1.1) 1.49 N.S. -1.14 N.S. -2.67 0.0036
max dose(Gy) 52.17 (2.6) 49.12 (3.1) 48.45 (2.7) 48.10 (2.5) -1.38 N.S. -2.12 N.S. -0.73 N.S.
PTV PTV95(Gy) 44.92 (0.9) 40.53 (2.4) 41.42 (2.2) 39.68 (2.9) 2.15 N.S. -2.15 N.S. -4.39 0.033
PTVmin 42.88 (1.8) 38.05 (3.0) 38.31 (3.0) 37.57 (2.3) 0.67 N.S. -1.28 N.S. -1.96 N.S.
ITV ITVmin 44.88 (1.4) 41.01 (2.2) 42.38 (2.2) 40.66 (1.8) 3.22 N.S. -0.86 N.S. -4.2 0.0094
Lung-ITV MLD(Gy) 5.72 (2.3) 5.28 (2.1) 5.31 (2.0) 5.33 (2.1) 0.61 N.S. 1.03 N.S. 0.42 N.S.
V20(%) 9.18 (4.6) 8.22 (4.3) 8.44 (4.3) 8.54 (4.4) 2.55 N.S. 3.68 N.S. 1.16 N.S.
V5(%) 28.21 (9.5) 27.57 (9.6) 27.85 (9.4) 28.03 (9.6) 1.02 N.S. 1.65 N.S. 0.63 N.S.
HI 1.21 (0.09) 1.26 (0.09) 1.26 (0.10) 1.27 (0.07) -0.34 N.S. 0.48 N.S. 0.82 N.S.
CI 2.69 (0.56) 2.71 (0.38) 2.92 (0.60) 2.86 (0.41) 7.19 N.S. 5.30 N.S. -2.04 N.S.
N.S., not significant.
Abbreviations: SHM, scatter homogeneous mode, CCC, C.C.Convolution, SP, Superposition, MC, Monte Carlo.
PTV, planning target volume. ITV, internal target volume.
HI, homogeneity index. CI, conformity index.
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of ITV and PTV, CCC and SP both had similar dose
volume histograms to XVMC.
Differences in dose volume indices
Table 3 lists the mean values and standard deviations of
the relative differences in several dose volume indices
between the different algorithms. The dose discrepancies
between SHM and the others for the median values of
the IC dose were -5.5% (median, range: -4.1 to -6.2%)
and of the PTV95 were -9.8% (range: -7.8 to -11.7%).
Compared to XVMC, SHM greatly overestimated the
doses in IC doses and PTV95. The differences in mean
d o s e sw e r e3 . 1 6G y( 6 . 6 % )f o rI Cd o s e s ,a n d5 . 2 4G y
(10.9%) for PTV95. From this study, an isocentric
clinical dose of 48 Gy with Clarkson-type calculation in
JCOG 0403 was equivalent to IC 45.4 Gy with CCC,
46.0 Gy with SP and 44.84 Gy with XVMC.
Differences were noted in IC doses between SP and
XVMC (-2.67%, p=0.0036), and in PTV95 between SP
and XVMC (-4.39%, p=0.033). We also observed differ-
ences in ITV min doses between SP and XVMC (-4.2%,
p=0.0094). In contrast, we observed no significant dif-
ferences between CCC and XVMC, and between CCC
and SP. No significant differences were found among
the four algorithms in conformity index (CI, which is
the treated volume, defined as the volume enclosed by
the isodose curve of the PTVmin, divided by the PTV
volume), homogeneity index (HI, which is the maximal
dose divided by the minimal dose), mean lung dose
(MLD), V20 (percentage of volume covered by the 20
Gy isodose line) and PTV min.
Discussion
In previous section, the dose distributions of the 20
cases calculated with SHM, CCC, SP and XVMC were
compared each other. For a fixed monitor unit normali-
zation, which is considered to be a ‘fair’ comparison
between the algorithms, CCC, SP, and XVMC gave
almost the same results on actual patient CT scans.
More precisely, no significant differences were observed
in lung doses such as MLD and V20. In addition, there
were no significant differences between CCC and
XVMC, and between CCC and SP. On the other hand,
SP gave significantly different results of IC and PTV95
and ITVmin dose from XVMC, that is, SP produced a
higher dose than XVMC. This now raises the question
of what factors makes these differences. The tumor loca-
tion and/or ITV volume could be one of the candidates.
Although we consider the relationships between these
factors and differences, it was not demonstrated clearly
to which location and size the differences are significant.
For instance, Figure 5 shows that there is a negative
association of IC dose between SP and XVMC. On the
other hand, the difference of beam modeling for each
TPS can be the other candidate to yield the reason why
the dose indices in SP are a little bit higher than that in
XVMC. As seen in Table 2, comparative measurements
have shown that CCC, SP and XVMC were very close
to actual measurements in the homogeneous phantom.
All agreed with each other within 1.0% accuracy. How-
ever, it was also found that the result of SP gave the
1.3% larger dose than that of XVMC in 3 × 3 cm
2
square field. From this fact, we concluded that a part of
difference between SP and XVMC observed in patient
study was caused by the modeling of TPS.
For SRT planning, accuracy in the dose calculation is
required because of the heterogeneity in lung tissue. It
is acknowledged that CCC can accurately predict the
Figure 3 The cumulative DVHs for the ITV, PTV and (Lung-PTV)
using fixed monitor units for case 13.
Figure 4 Dose profiles in the longitudinal (y) direction of case
11 (a) and 13 (b). The red, blue, purple, and green curves
represent the dose profiles of the SHM, CCC, SP, and MC,
respectively.
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potentially the most powerful dose calculation algo-
rithms in radiotherapy [21]. However, due to long calcu-
lation times and the huge computational power needed,
XVMC algorithms have not seen widespread clinical use
[22]. On our TPS, the CCC algorithm (Pinnacle
3
ver.7.4i) is approximately 2.5 times faster than XVMC
(Monaco ver.2.03) with a small loss in accuracy (10 min
vs. 25 min). In addition, we found overall that in SRT
planning, the CCC and SP algorithm can reproduce the
dose distribution calculated by XVMC very well. Thus,
they remain attractive options for routine use in the
hospital due to their short computation times.
It is well known that target dose tends to be lower with
CCC than with Clarkson. Generally, this implies that pen-
cil beam-like algorithms such as SHM tend to give the
wrong impression that a good PTV coverage has been
achieved when in reality this is not the case. The reason
for this is lateral electron scattering, which is neglected by
Clarkson [23]. Therefore, simple algorithms such as SHM
especially overestimate the dose in the interface between
the target and lung tissue [24]. Our findings have shown
agreement with a previous study [9,25]. From this study,
an isocentric clinical dose of 48 Gy with the Clarkson
algorithm in JCOG 0403 was equivalent to PTV95 dose of
40.5 Gy with CCC in JCOG 0702 (data not shown).
It is concluded that CCC and SP delivered almost the
same dose distribution when used in combination open
fields like SRT for lung cancer. Our analysis and inter-
pretation is deficient in needing further investigation to
ascertain whether CCC and SP are preferable to manage
leakage and radiation quality in IMRT.
Conclusions
This is the first study comparing XVMC with SHM,
CCC, and SP for lung SRT treatment plans. The dose
distributions in actual CT scans from CCC and SP
almost agreed with those of XVMC at energy of 6 MV.
An IC dose of 48 Gy with the Clarkson-type algorithm
in JCOG 0403 was equivalent to PTV95 dose of 40.5 Gy
with CCC in JCOG 0702. We should take careful note
of the interpretational problems arising from this discre-
pancy. As reported in previous studies, our work clearly
confirms that the actual practice of relying solely on
Clarkson-type algorithm may be inappropriate for SRT
planning. The CCC and SP were close to XVMC simu-
lations which we assumed to be the best representation
of the real dose distributions in lung SRT. Therefore,
CCC and SP are still reliable methods for SRT of lung
tumors.
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